ERBB2 and neoplasm: Subsequent studies have also confirmed that CCL19 can be used as an adjuvant for immunization with intradermal gene guns in a Her2/neu mouse tumor model, with enhanced vaccine efficacy (Nguyen-Hoai et al., 2012).